Session

Back to Programme Overview

Outcome in minimally invasive surgery for BPO

Poster Session 22

  • Location:
    Room Amsterdam, North Hall (Level 1)
  • Chairs:
     T. Hermanns, Zürich (CH)
     J.Y. Park, Gangneung (KR)
     C.G. Roehrborn, Dallas (US)
  • Aims and objectives of this session

    The outcomes in minimally invasive surgery for BPO will be discussed from the perspective of complications.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
296
Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a prospective randomized trial

By: Netsch C.1, Becker B.1, Tiburtius C.1, Moritz C.1, Venneri Becci A.1, Herrmann T.2, Gross A.1

Institutes: 1Asklepios Klinik Barmbek, Dept. of Urology, Hamburg, Germany, 2MHH Medical School of Hanover, Dept. of Urology, Hanover, Germany

290
Treatment failure and perioperative complications after GreenLight laser vaporisation of the prostate

By: Calandriello M., Abbinante M., De Giorgi G., Giannarini G., Crestani A., Ficarra V.

Institutes: Academic Medical Centre Hospital Santa Maria Della Misericordia, Dept. of Urology, Udine, Italy

291
Postoperative dysuria after high- and low-power en-bloc no-touch HoLEP

By: Cracco C.M., Ingrosso M., Russo N., Scoffone C.M.

Institutes: Ospedale Cottolengo, Dept. of Urology, Turin, Italy

300
Low-power versus high-power en-bloc no-touch HoLEP: Comparing feasibility, safety and efficacy

By: Cracco C.M., Ingrosso M., Russo N., Scoffone C.M.

Institutes: Ospedale Cottolengo, Dept. of Urology, Turin, Italy

292
One-fourth of patients may report impairment of erectile function after holmium laser enucleation of the prostate (HoLEP)

By: Marquette T., Comat V., Capon G., Pasticier G., Bernhard J., Bensadoun H., Ferriere J., Robert G.

Institutes: CHU bordeaux, Dept. of Urology, Bordeaux, France

293
Can preopeative detrusor underactivity have an impact on surgical outcomes of laser prostatectomy: Comparison in serial 3-year follow-up outcomes between 120-W lithium triborate photoselective vaporization of the prostate (PVP) and holmium laser enucleation of the prostate (HoLEP)

By: Ahn C.H.2, Park J.1, Sun D.Y.2, Cho S.Y.1, Baik S.3, Chun S.J.4, You K.H.5, Cho M.C.1, Park K.2, Jeong H.1, Kim S.W.2, Paick J-S.2, Son H.1

Institutes: 1Boramae Medical Center, Dept. of Urology, Seoul, South Korea, 2Seoul National University, Dept. of Urology, Seoul, South Korea, 3Chosun University School of Medicine, Dept. of Urology, Gwangju, South Korea, 4Gwangju Verterans Hospital, Dept. of Urology, Gwangju, South Korea, 5Gwanmyeong Sungae Hospital, Dept. of Urology, Gwanmyeong, South Korea

294
Results of laser Greenlight® 180-W XPS vaporization for benign prostatic obstruction in patients with antithrombotic therapy or platelet aggregation inhibitors: A multicentric study

By: Lefevre M.1, Huet R.1, Lebdai S.2, Ouzaid I.3, Fontenil A.2, Gerbaud F.3, Ravery V.3, Azzouzi A-R.2, Peyronnet B.1, Bensalah K.1, Verhoest G.1, Vincendeau S.1, Mathieu R.1

Institutes: 1Rennes University Hospital, Dept. of Urology, Rennes, France, 2University Hospital of Angers, Dept. of Urology, Angers, France, 3Bichat-Claude Bernard Hospital, Dept. of Urology, Paris, France

295
Photoselective vaporization of the prostate with Greenlight laser XPS 180W, Green laser enucleation of the prostate and open prostatectomy for benign prostatic obstruction: A comparative analysis of perioperative and short term results

By: Huet R.1, Vincendeau S.1, Sebe P.2, Peyronnet B.1, Guillé F.1, Colau A.2, Verhoest G.1, Bensalah K.1, Guillonneau B.2, Mathieu R.1

Institutes: 1CHU Rennes, Dept. of Urology, Rennes, France, 2Les Diaconnesses Croix St Simon Hospital, Dept. of Urology, Paris, France

297
Holmium laser enucleation of the prostate (HoLEP) does not prevent from all bleeding complications in patients on anti-coagulant therapy

By: Comat V., Marquette T., Capon G., Bernhard J-C., Pasticier G., Bensadoun H., Ferrière J-M., Robert G.

Institutes: Chu Bordeaux, Dept. of Urologie, Bordeaux, France

298
Thulium laser prostate enucleation in refractory urinary retention: Operative and functional outcomes in a large cohort of patients

By: Carmignani L.1, Pastore A.2, Picozzi S.1, Vizziello D.1, Finkelberg E.1, Ratti D.1, Schirinzi M1, Saccà A.3, Pisano F4, Maruccia S.5

Institutes: 1San Donato Hospital Milan, Dept. of Urology, Milan, Italy, 2Sapienza University of Rome, Urology Division, Latina, Italy, 3Papa Giovanni XXIII, Dept. of Urology, Bergamo, Italy, 4Città Della Salute E Della Scienza, Dept. of Urology, Turin, Italy, 5Istituti Clinici Zucchi, Dept. of Urology, Monza, Italy

299
Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate on a large cohort of patients with benign prostatic obstruction: Long term outcomes

By: Pastore A.L., Palleschi G., Al Rawashdah S., Fuschi A, Velotti G., Leto A., Al Salhi Y., Petrozza V., Carbone A.

Institutes: Sapienza University of Rome, Dept. of Medico Surgical Sciences and Biotechnologies, Latina, Italy

301
Convective radiofrequency water vapor energy ablation effectively treats lower urinary tract symptoms due to benign prostatic enlargement regardless of obesity while preserving erectile and ejaculatory function: Results of a multicenter, randomized, controlled trial

By: Gupta N., Köhler T., McVary K.

Institutes: Southern Illinois University, Dept. of Urology, Springfield, United States of America

302
Suprapubic catheter insertion: What is the harm?

By: Donaldson J., Murray I., Janjua K., Mitchell I.

Institutes: Victoria Hospital, Dept. of Urology, Kirkcaldy, United Kingdom

Complications in minimally invasive surgery for LUTS
 C.G. Roehrborn, Dallas (US)